A Case of Schizophrenia in a Young Male Adult with no History of Substance Abuse: Impact of Clinical Pharmacists’ Interventions on Patient Outcome
Schizophrenia is a chronic and severe mental disorder characterized by distortions in thinking, perception, emotions, language, sense of self, and behaviour. This report presents the role of clinical pharmacists in the management of a patient diagnosed with schizophrenia with symptoms of paranoia. A...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Case Reports in Psychiatry |
| Online Access: | http://dx.doi.org/10.1155/2020/3419609 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832547102596530176 |
|---|---|
| author | Mercy N. A. Opare-Addo Josephine Mensah Grace Owusu Aboagye |
| author_facet | Mercy N. A. Opare-Addo Josephine Mensah Grace Owusu Aboagye |
| author_sort | Mercy N. A. Opare-Addo |
| collection | DOAJ |
| description | Schizophrenia is a chronic and severe mental disorder characterized by distortions in thinking, perception, emotions, language, sense of self, and behaviour. This report presents the role of clinical pharmacists in the management of a patient diagnosed with schizophrenia with symptoms of paranoia. A gainfully employed young African male adult reported to be roaming around town moving from one bank to another was arrested. The patient was referred to the psychiatric unit of a hospital and diagnosed with schizophrenia. Key interventions offered included rapid tranquilization, electroconvulsive therapy, and psychotherapy. Medications administered to the patient while on admission included IV diazepam, IM haloperidol, IV Ketamine, IM flupentixol, olanzapine tablets, and trihexyphenidyl tablets. Issues raised by clinical pharmacists during the patient’s admission included need for alternative medication for rapid tranquilization, need for initial investigations and documentation of the patient’s vitals, initiation of antipsychotic therapy without initial monitoring and screening for substance abuse, inappropriate dose at initiation of antipsychotic medications, untreated indication, and incidence of missed doses. Interventions by the clinical pharmacists contributed to improvement in the patient’s symptoms prior to hospital discharge. The case proves that it is critical for clinical pharmacists to be involved in the multidisciplinary team during management of patients with psychosis. |
| format | Article |
| id | doaj-art-ac7c72e4079742d685a4acbcf33e219d |
| institution | Kabale University |
| issn | 2090-682X 2090-6838 |
| language | English |
| publishDate | 2020-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Psychiatry |
| spelling | doaj-art-ac7c72e4079742d685a4acbcf33e219d2025-02-03T06:46:05ZengWileyCase Reports in Psychiatry2090-682X2090-68382020-01-01202010.1155/2020/34196093419609A Case of Schizophrenia in a Young Male Adult with no History of Substance Abuse: Impact of Clinical Pharmacists’ Interventions on Patient OutcomeMercy N. A. Opare-Addo0Josephine Mensah1Grace Owusu Aboagye2Department of Pharmacy Practice, Kwame Nkrumah University of Science and Technology (KNUST), PMB, U.P.O., Kumasi, GhanaDepartment of Surgery, Pharmacy Unit, Korle Bu Teaching Hospital, P.O. Box 77, Accra, GhanaDepartment of Psychiatry, Korle Bu Teaching Hospital, P.O. Box 77, Accra, GhanaSchizophrenia is a chronic and severe mental disorder characterized by distortions in thinking, perception, emotions, language, sense of self, and behaviour. This report presents the role of clinical pharmacists in the management of a patient diagnosed with schizophrenia with symptoms of paranoia. A gainfully employed young African male adult reported to be roaming around town moving from one bank to another was arrested. The patient was referred to the psychiatric unit of a hospital and diagnosed with schizophrenia. Key interventions offered included rapid tranquilization, electroconvulsive therapy, and psychotherapy. Medications administered to the patient while on admission included IV diazepam, IM haloperidol, IV Ketamine, IM flupentixol, olanzapine tablets, and trihexyphenidyl tablets. Issues raised by clinical pharmacists during the patient’s admission included need for alternative medication for rapid tranquilization, need for initial investigations and documentation of the patient’s vitals, initiation of antipsychotic therapy without initial monitoring and screening for substance abuse, inappropriate dose at initiation of antipsychotic medications, untreated indication, and incidence of missed doses. Interventions by the clinical pharmacists contributed to improvement in the patient’s symptoms prior to hospital discharge. The case proves that it is critical for clinical pharmacists to be involved in the multidisciplinary team during management of patients with psychosis.http://dx.doi.org/10.1155/2020/3419609 |
| spellingShingle | Mercy N. A. Opare-Addo Josephine Mensah Grace Owusu Aboagye A Case of Schizophrenia in a Young Male Adult with no History of Substance Abuse: Impact of Clinical Pharmacists’ Interventions on Patient Outcome Case Reports in Psychiatry |
| title | A Case of Schizophrenia in a Young Male Adult with no History of Substance Abuse: Impact of Clinical Pharmacists’ Interventions on Patient Outcome |
| title_full | A Case of Schizophrenia in a Young Male Adult with no History of Substance Abuse: Impact of Clinical Pharmacists’ Interventions on Patient Outcome |
| title_fullStr | A Case of Schizophrenia in a Young Male Adult with no History of Substance Abuse: Impact of Clinical Pharmacists’ Interventions on Patient Outcome |
| title_full_unstemmed | A Case of Schizophrenia in a Young Male Adult with no History of Substance Abuse: Impact of Clinical Pharmacists’ Interventions on Patient Outcome |
| title_short | A Case of Schizophrenia in a Young Male Adult with no History of Substance Abuse: Impact of Clinical Pharmacists’ Interventions on Patient Outcome |
| title_sort | case of schizophrenia in a young male adult with no history of substance abuse impact of clinical pharmacists interventions on patient outcome |
| url | http://dx.doi.org/10.1155/2020/3419609 |
| work_keys_str_mv | AT mercynaopareaddo acaseofschizophreniainayoungmaleadultwithnohistoryofsubstanceabuseimpactofclinicalpharmacistsinterventionsonpatientoutcome AT josephinemensah acaseofschizophreniainayoungmaleadultwithnohistoryofsubstanceabuseimpactofclinicalpharmacistsinterventionsonpatientoutcome AT graceowusuaboagye acaseofschizophreniainayoungmaleadultwithnohistoryofsubstanceabuseimpactofclinicalpharmacistsinterventionsonpatientoutcome AT mercynaopareaddo caseofschizophreniainayoungmaleadultwithnohistoryofsubstanceabuseimpactofclinicalpharmacistsinterventionsonpatientoutcome AT josephinemensah caseofschizophreniainayoungmaleadultwithnohistoryofsubstanceabuseimpactofclinicalpharmacistsinterventionsonpatientoutcome AT graceowusuaboagye caseofschizophreniainayoungmaleadultwithnohistoryofsubstanceabuseimpactofclinicalpharmacistsinterventionsonpatientoutcome |